Report Detail
Global Prostate-specific Antigen (PSA) Testing Market Size, Status and Forecast 2019-2025
- RnM3672053 |
- 16 August, 2019 |
- Global |
- 132 Pages |
- QYResearch |
- Other
Prostate-specific antigen (PSA) is a protein secreted only by epithelial prostate cells, and its elevation in serum is used to detect prostate cancer in men.Elevated PSA levels are associated with prostatitis, inflammation of the prostate or benign forms of prostatic hyperplasia, making it a valuable tumor marker for prostate cancer.The use of serology-based biomarkers for the diagnosis of prostate cancer has stimulated the need for prostate-specific antigen (PSA).
In 2018, the global Prostate-specific Antigen (PSA) Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Prostate-specific Antigen (PSA) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate-specific Antigen (PSA) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA
Market segment by Type, the product can be split into
CLIA Method
ELISA Method
Market segment by Application, split into
Screening
Post-treatment Monitoring
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Prostate-specific Antigen (PSA) Testing status, future forecast, growth opportunity, key market and key players.
To present the Prostate-specific Antigen (PSA) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Prostate-specific Antigen (PSA) Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type (2014-2025)
- 1.4.2 CLIA Method
- 1.4.3 ELISA Method
- 1.5 Market by Application
- 1.5.1 Global Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2025)
- 1.5.2 Screening
- 1.5.3 Post-treatment Monitoring
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Prostate-specific Antigen (PSA) Testing Market Size
- 2.2 Prostate-specific Antigen (PSA) Testing Growth Trends by Regions
- 2.2.1 Prostate-specific Antigen (PSA) Testing Market Size by Regions (2019-2025)
- 2.2.2 Prostate-specific Antigen (PSA) Testing Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Prostate-specific Antigen (PSA) Testing Market Size by by Players
- 3.1.1 Global Prostate-specific Antigen (PSA) Testing Revenue by by Players (2014-2019)
- 3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)
- 3.2 Prostate-specific Antigen (PSA) Testing Key Players Head office and Area Served
- 3.3 Key Players Prostate-specific Antigen (PSA) Testing Product/Solution/Service
- 3.4 Date of Enter into Prostate-specific Antigen (PSA) Testing Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Prostate-specific Antigen (PSA) Testing Market Size by Type (2014-2019)
- 4.2 Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2014-2019)
5 North America
- 5.1 North America Prostate-specific Antigen (PSA) Testing Market Size (2014-2019)
- 5.2 Prostate-specific Antigen (PSA) Testing Key Players in North America
- 5.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Type
- 5.4 North America Prostate-specific Antigen (PSA) Testing Market Size by Application
6 Europe
- 6.1 Europe Prostate-specific Antigen (PSA) Testing Market Size (2014-2019)
- 6.2 Prostate-specific Antigen (PSA) Testing Key Players in Europe
- 6.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type
- 6.4 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application
7 China
- 7.1 China Prostate-specific Antigen (PSA) Testing Market Size (2014-2019)
- 7.2 Prostate-specific Antigen (PSA) Testing Key Players in China
- 7.3 China Prostate-specific Antigen (PSA) Testing Market Size by Type
- 7.4 China Prostate-specific Antigen (PSA) Testing Market Size by Application
8 Japan
- 8.1 Japan Prostate-specific Antigen (PSA) Testing Market Size (2014-2019)
- 8.2 Prostate-specific Antigen (PSA) Testing Key Players in Japan
- 8.3 Japan Prostate-specific Antigen (PSA) Testing Market Size by Type
- 8.4 Japan Prostate-specific Antigen (PSA) Testing Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size (2014-2019)
- 9.2 Prostate-specific Antigen (PSA) Testing Key Players in Southeast Asia
- 9.3 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Type
- 9.4 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Application
10 India
- 10.1 India Prostate-specific Antigen (PSA) Testing Market Size (2014-2019)
- 10.2 Prostate-specific Antigen (PSA) Testing Key Players in India
- 10.3 India Prostate-specific Antigen (PSA) Testing Market Size by Type
- 10.4 India Prostate-specific Antigen (PSA) Testing Market Size by Application
11 Central & South America
- 11.1 Central & South America Prostate-specific Antigen (PSA) Testing Market Size (2014-2019)
- 11.2 Prostate-specific Antigen (PSA) Testing Key Players in Central & South America
- 11.3 Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Type
- 11.4 Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Application
12 International Players Profiles
- 12.1 Abbott
- 12.1.1 Abbott Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Prostate-specific Antigen (PSA) Testing Introduction
- 12.1.4 Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019))
- 12.1.5 Abbott Recent Development
- 12.2 Boston Scientific Corporation
- 12.2.1 Boston Scientific Corporation Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Prostate-specific Antigen (PSA) Testing Introduction
- 12.2.4 Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
- 12.2.5 Boston Scientific Corporation Recent Development
- 12.3 Bayer AG
- 12.3.1 Bayer AG Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Prostate-specific Antigen (PSA) Testing Introduction
- 12.3.4 Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
- 12.3.5 Bayer AG Recent Development
- 12.4 Siemens Healthcare
- 12.4.1 Siemens Healthcare Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Prostate-specific Antigen (PSA) Testing Introduction
- 12.4.4 Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
- 12.4.5 Siemens Healthcare Recent Development
- 12.5 DiaSorin
- 12.5.1 DiaSorin Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Prostate-specific Antigen (PSA) Testing Introduction
- 12.5.4 DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
- 12.5.5 DiaSorin Recent Development
- 12.6 Roche
- 12.6.1 Roche Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Prostate-specific Antigen (PSA) Testing Introduction
- 12.6.4 Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
- 12.6.5 Roche Recent Development
- 12.7 Beckman Coulter
- 12.7.1 Beckman Coulter Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Prostate-specific Antigen (PSA) Testing Introduction
- 12.7.4 Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
- 12.7.5 Beckman Coulter Recent Development
- 12.8 PerkinElmer
- 12.8.1 PerkinElmer Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Prostate-specific Antigen (PSA) Testing Introduction
- 12.8.4 PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
- 12.8.5 PerkinElmer Recent Development
- 12.9 Tosoh
- 12.9.1 Tosoh Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Prostate-specific Antigen (PSA) Testing Introduction
- 12.9.4 Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
- 12.9.5 Tosoh Recent Development
- 12.10 Ortho Clinical
- 12.10.1 Ortho Clinical Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Prostate-specific Antigen (PSA) Testing Introduction
- 12.10.4 Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2014-2019)
- 12.10.5 Ortho Clinical Recent Development
- 12.11 Fujirebio
- 12.12 Mediwatch
- 12.13 BodiTech
- 12.14 Bristol-Myers Squibb Company
- 12.15 GE Healthcare
- 12.16 Endocare
- 12.17 Merck＆Co.
- 12.18 Medtronic
- 12.19 Sanofi-Aventis SA
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Prostate-specific Antigen (PSA) Testing. Industry analysis & Market Report on Prostate-specific Antigen (PSA) Testing is a syndicated market report, published as Global Prostate-specific Antigen (PSA) Testing Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Prostate-specific Antigen (PSA) Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
